Ingredion (INGR) Cash & Equivalents (2009 - 2026)

Ingredion has reported Cash & Equivalents for 18 years, with the latest figure at $914.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 9.2% year-over-year to $914.0 million; the trailing twelve-month figure through Mar 2026 stood at $914.0 million (up 9.2% YoY), and the FY2025 full-year result was $1.0 billion, up 3.31% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $914.0 million, down from $1.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $1.0 billion in Q4 2025, with the low at $236.0 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $596.2 million across 5 years, with a median of $471.5 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 43.75% — and 2024, when it soared 161.79%.
• Ingredion's Cash & Equivalents stood at $236.0 million in 2022, then soared by 69.92% to $401.0 million in 2023, then surged by 148.63% to $997.0 million in 2024, then grew by 3.31% to $1.0 billion in 2025, then slipped by 11.26% to $914.0 million in 2026.
• The last three Cash & Equivalents figures came in at $914.0 million (Q1 2026), $1.0 billion (Q4 2025), and $915.0 million (Q3 2025), per Business Quant data.